Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ajay Vora

Showing results (151-160 of 166) with videos related to

Pageof 17
Sort By:
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
Blood|August 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS studyTeena Bhatla, Laura E Hogan, David T Teachey, et al.
Blood Advances|October 11, 2023
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapyMaria Gabelli, Macarena Oporto-Espuelas, Saskia Burridge, et al.
Blood Cancer Journal|April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access schemeMacarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Blood Advances|January 18, 2019
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALLLina Hamadeh, Amir Enshaei, Claire Schwab, et al.
Blood|August 30, 2023
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALLSara Ghorashian, Giovanna Lucchini, Rachel Richardson, et al.
Blood|November 14, 2013
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupTrudy D Buitenkamp, Shai Izraeli, Martin Zimmermann, et al.
Nature Communications|January 22, 2019
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Nature Medicine|July 2, 2024
Benefits for children with suspected cancer from routine whole-genome sequencingAngus Hodder, Sarah M Leiter, Jonathan Kennedy, et al.
Pageof 17

Showing results (151-160 of 166) with videos related to

Sort By:
Pageof 17
Nature Communications|November 27, 2019
Identification of four novel associations for B-cell acute lymphoblastic leukaemia riskJayaram Vijayakrishnan, Maoxiang Qian, James B Studd, et al.
Blood|August 19, 2024
Daratumumab in pediatric relapsed/refractory acute lymphoblastic leukemia or lymphoblastic lymphoma: the DELPHINUS studyTeena Bhatla, Laura E Hogan, David T Teachey, et al.
Blood Advances|October 11, 2023
Maintenance therapy for early loss of B-cell aplasia after anti-CD19 CAR T-cell therapyMaria Gabelli, Macarena Oporto-Espuelas, Saskia Burridge, et al.
Blood Cancer Journal|April 15, 2024
Intention-to-treat outcomes utilising a stringent event definition in children and young people treated with tisagenlecleucel for r/r ALL through a national access schemeMacarena Oporto Espuelas, Saskia Burridge, Amy A Kirkwood, et al.
Nature Medicine|October 13, 2021
CAR T cells with dual targeting of CD19 and CD22 in pediatric and young adult patients with relapsed or refractory B cell acute lymphoblastic leukemia: a phase 1 trialShaun Cordoba, Shimobi Onuoha, Simon Thomas, et al.
Blood Advances|January 18, 2019
Validation of the United Kingdom copy-number alteration classifier in 3239 children with B-cell precursor ALLLina Hamadeh, Amir Enshaei, Claire Schwab, et al.
Blood|August 30, 2023
CD19/CD22 targeting with cotransduced CAR T cells to prevent antigen-negative relapse after CAR T-cell therapy for B-cell ALLSara Ghorashian, Giovanna Lucchini, Rachel Richardson, et al.
Blood|November 14, 2013
Acute lymphoblastic leukemia in children with Down syndrome: a retrospective analysis from the Ponte di Legno study groupTrudy D Buitenkamp, Shai Izraeli, Martin Zimmermann, et al.
Nature Communications|January 22, 2019
Author Correction: Genome-wide association study identifies susceptibility loci for B-cell childhood acute lymphoblastic leukemiaJayaram Vijayakrishnan, James Studd, Peter Broderick, et al.
Nature Medicine|July 2, 2024
Benefits for children with suspected cancer from routine whole-genome sequencingAngus Hodder, Sarah M Leiter, Jonathan Kennedy, et al.
Pageof 17